John M Nolan Selected Research

Zeaxanthins

1/2020	Circulating Micronutrient Biomarkers Are Associated With 3 Measures of Frailty: Evidence From the Irish Longitudinal Study on Ageing.
1/2018	The Relationship Between Plasma Concentrations of Lutein and Zeaxanthin with Self-Reported and Actual Prevalence of AMD in an Irish Population-Based Sample.
8/2015	Macular response to supplementation with differing xanthophyll formulations in subjects with and without age-related macular degeneration.
4/2011	Changes in macular pigment optical density and serum concentrations of lutein and zeaxanthin in response to weight loss.
1/2010	Macular pigment optical density in an ageing Irish population: The Irish Longitudinal Study on Ageing.
1/2008	Transport and retinal capture of lutein and zeaxanthin with reference to age-related macular degeneration.
1/2007	Risk factors for age-related maculopathy are associated with a relative lack of macular pigment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John M Nolan Research Topics

Disease

24	Macular Degeneration (Age-Related Maculopathy) 01/2018 - 01/2007
4	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2014
4	Cataract (Cataracts) 01/2017 - 10/2009
3	Eye Diseases (Eye Disease) 10/2017 - 08/2013
2	vitreous floaters 10/2021 - 12/2019
2	Retinal Diseases 10/2016 - 06/2016
2	Birth Weight (Birth Weights) 04/2010 - 06/2009
1	Blister (Bulla) 01/2022
1	Cicatrix (Scar) 01/2022
1	Dementia (Dementias) 01/2022
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2022
1	Retinal Detachment (Retinal Detachments) 01/2022
1	Cognitive Dysfunction 01/2022
1	Frailty 01/2020
1	Disease Progression 01/2018
1	Glaucoma 01/2018
1	Astigmatism 05/2016
1	Weight Loss (Weight Reduction) 04/2011

Drug/Important Bio-Agent (IBA)

16	Macular PigmentIBA 01/2018 - 01/2007
13	Carotenoids (Carotene)IBA 01/2022 - 01/2007
7	LuteinIBA 01/2020 - 01/2007
7	ZeaxanthinsIBA 01/2020 - 01/2007
6	Retinaldehyde (Retinal)IBA 01/2017 - 01/2008
5	AntioxidantsIBA 12/2019 - 03/2008
3	ZincIBA 10/2021 - 04/2007
3	XanthophyllsIBA 01/2018 - 02/2014
3	meso-zeaxanthinIBA 10/2017 - 01/2010
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2022 - 01/2018
2	Vitamin E FDA LinkGeneric 01/2022 - 04/2007
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 10/2021 - 04/2007
2	MicronutrientsIBA 10/2021 - 01/2020
2	Drinking WaterIBA 04/2010 - 06/2009
2	perfluorooctanoic acidIBA 04/2010 - 06/2009
1	Lysine (L-Lysine)FDA Link 10/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Vitamin D FDA LinkGeneric 01/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 02/2014
1	Ranibizumab (Lucentis)FDA Link 01/2013
1	Vitamin A (Retinol)FDA LinkGeneric 10/2011
1	CarbohydratesIBA 10/2011
1	Complement Factor H (Factor H)IBA 01/2009
1	EstersIBA 04/2007
1	SeleniumIBA 04/2007

Therapy/Procedure

3	Intraocular Lenses (Intraocular Lens) 05/2016 - 10/2009
1	Slit Lamp 01/2022
1	Percutaneous Collagen Induction 01/2022
1	Scleral Buckling 01/2022
1	Sutures (Suture) 01/2022
1	Stents 01/2022
1	Phacoemulsification 01/2016